• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼卡地平对充血性心力衰竭患者稳态时的血清地高辛浓度无显著影响。

Nicardipine does not significantly affect serum digoxin concentrations at the steady state of patients with congestive heart failure.

作者信息

Debruyne D, Commeau P, Grollier G, Huret B, Scanu P, Moulin M

机构信息

Laboratory of Pharmacology, University Hospital Centre of Caen, France.

出版信息

Int J Clin Pharmacol Res. 1989;9(1):15-9.

PMID:2707921
Abstract

Twenty patients in a stable condition suffering from congestive heart failure were treated with digoxin for at least three weeks and then with nicardipine concomitantly for five days. No statistically significant variation in serum digoxin concentrations determined at seven control times during a 24-hour period or in its mean concentration was found in the two groups of values examined before and after the concurrent nicardipine treatment. The mean increase of 6.8% in the AUC0----24h was not significant either. Since the maximum increase in serum digoxin concentrations at the steady state never exceeded 0.5 ng/ml, a toxic effect is not likely to occur in patients whose digoxin levels are normally monitored.

摘要

20例病情稳定的充血性心力衰竭患者接受地高辛治疗至少3周,然后同时加用尼卡地平治疗5天。在尼卡地平联合治疗前后检查的两组数值中,未发现24小时内7个对照时间点测定的血清地高辛浓度或其平均浓度有统计学意义的变化。AUC0-24h平均增加6.8%也无显著意义。由于稳态时血清地高辛浓度的最大增加值从未超过0.5 ng/ml,因此在常规监测地高辛水平的患者中不太可能发生毒性作用。

相似文献

1
Nicardipine does not significantly affect serum digoxin concentrations at the steady state of patients with congestive heart failure.尼卡地平对充血性心力衰竭患者稳态时的血清地高辛浓度无显著影响。
Int J Clin Pharmacol Res. 1989;9(1):15-9.
2
A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.地尔硫䓬与硝酸异山梨酯对慢性缺血性心力衰竭患者地高辛药效学和药代动力学影响的比较
Saudi Med J. 2002 Jun;23(6):725-31.
3
[Pharmacokinetics and pharmacodynamic effects of digoxin in dilated cardiomyopathies. Influence of nicardipine].[地高辛在扩张型心肌病中的药代动力学和药效学效应。尼卡地平的影响]
Arch Mal Coeur Vaiss. 1987 Nov;80(12):1773-83.
4
[Relation between serum levels and inotropic effect of digoxin in advanced cardiac failure during long-term treatment].
Arch Mal Coeur Vaiss. 1983 Dec;76(12):1399-408.
5
Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.与呋塞米预处理相比,米唑林治疗充血性心力衰竭患者。对洋地黄毒苷血药浓度的影响。
Z Kardiol. 1985;74 Suppl 2:24-6.
6
Interaction between digoxin and the calcium antagonists nicardipine and tiapamil.
Clin Ther. 1983;5(6):595-602.
7
[Serum levels and kinetics of digoxin in patients with hyperthyroidism (author's transl)].甲状腺功能亢进患者地高辛的血清水平及动力学(作者译)
G Ital Cardiol. 1980;10(7):836-42.
8
Enhanced cardiac effect of digoxin during quinidine treatment.奎尼丁治疗期间地高辛的心脏效应增强。
Arch Intern Med. 1979 May;139(5):519-21.
9
Digoxin may reduce the mortality rates in patients with congestive heart failure.地高辛可能降低充血性心力衰竭患者的死亡率。
Med Hypotheses. 2005;64(1):124-6. doi: 10.1016/j.mehy.2004.02.058.
10
[Digoxin: continuous or discontinuous treatment?].[地高辛:持续治疗还是间断治疗?]
Medicina (B Aires). 1998;58(3):271-6.

引用本文的文献

1
Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK).三个国家(日本、美国和英国)药品说明书中钙拮抗剂药代动力学相互作用信息的比较。
Eur J Clin Pharmacol. 2005 Aug;61(7):531-6. doi: 10.1007/s00228-005-0974-x. Epub 2005 Jul 23.
2
Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.尼卡地平。老年患者药理学及治疗效果综述。
Drugs Aging. 1993 Mar-Apr;3(2):165-87. doi: 10.2165/00002512-199303020-00007.
3
Calcium antagonists. Drug interactions of clinical significance.
钙拮抗剂。具有临床意义的药物相互作用。
Drug Saf. 1995 Sep;13(3):157-87. doi: 10.2165/00002018-199513030-00003.
4
Pharmacokinetic interactions with calcium channel antagonists (Part II).与钙通道拮抗剂的药代动力学相互作用(第二部分)。
Clin Pharmacokinet. 1991 Dec;21(6):448-60. doi: 10.2165/00003088-199121060-00005.